EW Today - Aug 07: Upgraded Sales Outlook Boost

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

EW Today - Aug 07: Upgraded Sales Outlook Boost

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your go-to guy for stock talk. I’ve been in the investing game for a while, and today we’re looking at Edwards Lifesciences, ticker EW. It was a pretty chill day, just a slight uptick of about 0.4%. Not exactly fireworks, but hey, it’s green!

So, what’s the scoop? Edwards Lifesciences barely moved, but it seems like some folks are feeling a bit more optimistic. A couple of investment firms made some big moves recently. Orser Capital Management dropped over $2 million into EW, and Assenagon Asset Management snagged over half a million shares. Sounds like they see potential, right?

Now, let’s talk about why people are buzzing. The big news is that there’s been an upgrade in the sales outlook for their structural heart portfolio. Basically, analysts are saying that this could be a game changer for the company. When you hear “game changer,” it usually gets people excited. Plus, analysts are giving it a “Moderate Buy” rating, so you know, there’s some confidence there.

Looking ahead, Edwards is on the radar for its structural heart products, which might really shake things up if they hit those new sales targets.

Alright, that’s a wrap for today! Just remember, I’m here to share info and keep it fun, not to give financial advice. Catch you later!

まだレビューはありません